Company Details
macleods-pharmaceuticals-ltd.
11,821
143,576
3254
macleodspharma.com
0
MAC_2163538
In-progress


MACLEODS PHARMACEUTICALS LTD. Company CyberSecurity Posture
macleodspharma.comA vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.
Company Details
macleods-pharmaceuticals-ltd.
11,821
143,576
3254
macleodspharma.com
0
MAC_2163538
In-progress
Between 750 and 799

MPL Global Score (TPRM)XXXX



No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.
MPL cyber incidents detection timeline including parent company and subsidiaries

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.


This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by list

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists
.png)
The event garnered deep insights into current trends, challenges, and opportunities, engaging over 175 senior delegates, industry leaders, and innovators.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of MACLEODS PHARMACEUTICALS LTD. is https://www.macleodspharma.com.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD.’s AI-generated cybersecurity score is 775, reflecting their Fair security posture.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not certified under SOC 2 Type 1.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not hold a SOC 2 Type 2 certification.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not listed as GDPR compliant.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not currently maintain PCI DSS compliance.
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not compliant with HIPAA regulations.
According to Rankiteo,MACLEODS PHARMACEUTICALS LTD. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
MACLEODS PHARMACEUTICALS LTD. operates primarily in the Pharmaceutical Manufacturing industry.
MACLEODS PHARMACEUTICALS LTD. employs approximately 11,821 people worldwide.
MACLEODS PHARMACEUTICALS LTD. presently has no subsidiaries across any sectors.
MACLEODS PHARMACEUTICALS LTD.’s official LinkedIn profile has approximately 143,576 followers.
MACLEODS PHARMACEUTICALS LTD. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, MACLEODS PHARMACEUTICALS LTD. does not have a profile on Crunchbase.
Yes, MACLEODS PHARMACEUTICALS LTD. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/macleods-pharmaceuticals-ltd..
As of January 23, 2026, Rankiteo reports that MACLEODS PHARMACEUTICALS LTD. has not experienced any cybersecurity incidents.
MACLEODS PHARMACEUTICALS LTD. has an estimated 5,510 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
Improper validation of specified type of input in M365 Copilot allows an unauthorized attacker to disclose information over a network.
Improper access control in Azure Front Door (AFD) allows an unauthorized attacker to elevate privileges over a network.
Azure Entra ID Elevation of Privilege Vulnerability
Moonraker is a Python web server providing API access to Klipper 3D printing firmware. In versions 0.9.3 and below, instances configured with the "ldap" component enabled are vulnerable to LDAP search filter injection techniques via the login endpoint. The 401 error response message can be used to determine whether or not a search was successful, allowing for brute force methods to discover LDAP entries on the server such as user IDs and user attributes. This issue has been fixed in version 0.10.0.
Runtipi is a Docker-based, personal homeserver orchestrator that facilitates multiple services on a single server. Versions 3.7.0 and above allow an authenticated user to execute arbitrary system commands on the host server by injecting shell metacharacters into backup filenames. The BackupManager fails to sanitize the filenames of uploaded backups. The system persists user-uploaded files directly to the host filesystem using the raw originalname provided in the request. This allows an attacker to stage a file containing shell metacharacters (e.g., $(id).tar.gz) at a predictable path, which is later referenced during the restore process. The successful storage of the file is what allows the subsequent restore command to reference and execute it. This issue has been fixed in version 4.7.0.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.